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Treatment of HER 14 cells with epidermai growth factor (EGF) or platelet-derived growth factor (PDGF) induced a translocation of phospholipase 
C-y (PLC-y) from cytosol to membrane. In such growth factor-treated cells, cytosolic PLC-)I was found to contain more phosphotyrosine than 
membrane-associated enzyme. Because these growth factors have been shown to promote both the physical association of PLC-y with their receptors 
and the subsequent phosphorylation of the enzyme directly by the membrane-bound receptor tyrosine kinases, the membrane assocation of PLC-y 
may simply be due to the formation of transient enzyme (receptor)-substrate (PLC-y) complexes. If this is the case, membrane-associated PLC-y 
would be expected to be released from membrane after undergoing tyrosine phosphorylation. However, tyrosine phosphorylation of membrane- 
associated PLC-y by the EGF receptor in vitro did not result in the release of PLC-y from membrane. Thus, the association of PLC-y with membrane 
would appear to involve more than enzyme-substrate complex. 
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1. INTRODUCTION 
The binding of platelet-derived growth factor 
(PDGF) and epidermal growth factor (EGF) to their 
respective receptors stimulates a phosphoinositide- 
specific phospholipase C (PLC), which hydrolyzes 
phosphatidylinositol 4,5-bisphosphate (PIPz) [ 11. The 
two products of PIP2 hydrolysis are both second 
messengers: diacylglycerol, which activates the Ca”/ 
phospholipid-dependent protein kinase C; and inositol 
1,4,5-trisphosphate, which mobilizes Ca2+ from intra- 
cellular stores [I]. The protein-tyrosine kinase activity 
of the growth factor receptors is essential for growth- 
factor induced PIP2 hydrolysis; mutant PDGF [2] and 
EGF [3] receptors lacking kinase activity fail to induce 
PIP2 hydrolysis, even though the ligand binding is not 
altered. 
cytosolic fractions of mammalian tissues and cultured 
cells, might translocate from cytosol to membrane in 
response to the growth factors. We investigated this 
possibility with HER 14 cells, which contain both EGF 
and PDGF receptors. 
2. MATERIALS AND METHODS 
The substrates of the receptor tyrosine kinases appear 
to include PLC-y, one of 4 PLC isoforms identified in 
mammalian tissues [4]. Treatment of responsive cells 
with EGF or PDGF results in a rapid increase in the 
phosphorylation of tyrosine and serine residues in PLC- 
y, but not in other isoforms [5-81. Four sites of tyrosine 
phosphorylation in PLC-y have been identified [9, lo]. 
In addition, EGF and PDGF receptors, when 
stimulated by ligands, bind tightly to and coim- 
munoprecipitate with PLC-y [5-8,11,12]. These results 
suggest that PLC-y, which exists mainly (> 80%) in 
HER 14 cells 1131, which were derived from NIH 3T3 clone 2.2 by 
transfecting with human EGF receptor DNA constructs, were 
generously provided by Dr. J. Schlessinger (Rorer Biotechnology, 
Inc., King of Prussia, PA). The cells were maintained in Dulbecco’s 
Modified Eagle’s medium (DMEM) with 10% fetal bovine serum 
(FBS) contained in 75 cm* stock flasks under a humidified at- 
mosphere of 95% air and 5% CO2 at 37°C. Cells were subcultured for 
experiments by plating 2 x lo6 cells in 100 mm-diameter dishes and 
allowing them to become SO-90% confluent, at which point they were 
placed in DMEM with 1% FBS overnight for subsequent study. 
2.1. Preparation of cell fractions 
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The cell dishes were incubated on ice for 30 min before treatment 
with growth factors for 5 min. The cells were then rinsed twice with 
ice-cold phosphate-buffered saline, scraped into homogenization buf- 
fer (200 ~1) containing 10 mM Tris-HCl, pH 7.2, 5 mM EGTA, 0.1 
mM dithiothreitol, 2 mM phenylmethylsulfonyl fluoride, 1 mM 
sodium orthovanadate, 10 mM sodium fluoride, 10 mM glycero- 
phosphate, leupeptin (10 pg/ml), and aprotinin- (10 fig/ml), and 
homoaenized bv 20 strokes with a Kontes Pellet Pestle Motor. The 
unruptured cells and nuclei were pelleted by centrifugation for 1 min 
at 1500 rpm in an Eppendorf microcentrifuge:The supernatants were 
then centrifuged at 100 000 x g for 20 min in a Beckman TL-100 table- 
top ultracentrifuge. The cytosolic fraction was derived from the 
supernatant of this centrifugation and the membrane fraction was 
derived from the pellet by dissolving it with extraction buffer contain- 
ing 20 mM Hepes, pH 7.2, 1% Triton X-100, 10% glycerol, 50 mM 
sodium fluoride, 1 mM phenylmethyl-sulfonyl fluoride, 1 mM 
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sodium orthovanadate, leupeptin (10 &ml), and aprotinin (10 
rg/ml). 
For the phosphorylation studies, cell proteins were metabolically 
labeled by incubating the cells with 0.5 mCi/ml [“Plorthophosphate 
(ICN) in phosphate-free Minimal Essential Medium plus 10% dialyz- 
ed FBS for 4 h at 37°C. Cells were then incubated on ice, stimulated 
with EGF, washed, and lysed with extraction buffer as described 
above. 
2.2. Immunoprecipitation and immunoblotting 
Immunoprecipitation was performed with a mixture of monoclonal 
antibodies to PLC-y [14], as previously described [15]. The im- 
munoprecipitates were washed with a buffer containing 1% Triton 
X-100, 1% deoxycholate, 0.1% SDS, 150 mM NaCl, and 50 mM Tris, 
pH 8.5. Immunoprecipitated proteins were released by the addition of 
200 ,ul of Laemmli buffer and heating for 5 min at 95°C. SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE) was performed with 
a 7.5% polyacrylamide gel by the method of Laemmli [16], and the 
separated proteins were then transferred to nitrocellulose for 2 h at 
50 V. After blocking with 2% bovine serum albumin, the filters were 
probed with a mixture of monoclonal antibodies to PLC-y or 
monoclonal antibodies to phosphotyrosine (ICN Immunochemicals). 
Immune complexes were detected with ‘ZSI-labeled protein A (Amer- 
sham) and autoradiography. 
2.3. Phosphoamino acid analysis 
[“‘PlPhosphoproteins were separated by SDS-PAGE with a 7.5% 
polyacrylamide gel. The [“P]PLC-7 band was cut from the dried gel 
and the protein was eluted as described [6] and treated with 5.7 N HCl 
at 100°C for 1 h. Phosphoamino acid analysis was performed as 
described [6]. 
3. RESULTS 
To investigate whether EGF and PDGF cause a 
translocation of PLC-y, cytosolic and membrane frac- 
tions were prepared from HER 14 cells that had or had 
not been treated with either EGF (100 ng/ml) or PDGF 
(50 ng/ml) for 5 min at 4°C. After proteins in each frac- 
tion were separated by SDS-PAGE and transferred to 
nitrocellulose sheets, the sheets were probed with 
monoclonal antibodies to PLC-7. The antibody-PLC-y 
complex was visualized with “I-labeled protein A and 
quantitated by measuring the “?-radioactivity asso- 
ciated with PLC-7 bands cut from the immunoblot. As 
shown in Fig. 1, EGF and PDGF treatment both caused 
a significant increase of PLC-y in membrane fractions 
(lane 3 vs. lane 4). Five independent experiments with 
EGF were performed. The results revealed that 5 + 29’0 
of the total PLC-y protein was associated in untreated 
cells. But upon treatment with EGF, PLC-7 in the 
membrane fraction increased 3-fold to 16 f 3%. 
We next investigated whether the state of tyrosine 
phosphorylation is different in PLC-y immunoprecipi- 
tated from cytosolic and membrane fractions of HER 
14 cells. As shown in lanes 5 and 6 of Fig. 1, cytosolic 
PLC-7 exhibited stronger reactivity to anti-tyrosine 
phosphate antibodies than did membrane PLC-7 in 
both EGF- and PDGF-treated cells. To confirm this 
observation, PLC-y was immunoprecipitated from 
HER 14 cells metabolically labeled with [32P]ortho- 
phosphate and separated by SDS-PAGE. We then 
analyzed the phosphoamino acid content of PLC-7 
34 
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Fig. 1. Effects of growth factors on the distribution and the tyrosine 
phosphorylation of PLC-y in cytosol and membrane. Lanes 1-4. 
Cytosolic and membrane fractions were obtained from HER 14 cells 
treated with 100 ng/ml EGF or 50 ng/ml PDGF as described in 
‘Materials and Methods’. The final volumes of cytosol and membrane 
fractions were adjusted to 200 ~1 and different volumes of the frac- 
tions were loaded onto 7.5% SDS-PAGE. For the EGF-treated cells 
(upper panel), the sample volume loaded was 10~1 for cytosol (lanes 
1 and 2) and 50~1 for membrane (lanes 3 and 4); for the PDGF-treated 
cells (lower panel), the sample volume was 5~1 for cytosol (lanes 1 and 
2) and 100,ul for membrane (lanes 3 and 4). Proteins were transferred 
from the gel to a nitrocellulose sheet and blotted with antibodies to 
PLC-7. Finally, the antibody-PLC-y complex was detected with lz51- 
labeled protein A and autoradiography. PLC-7 bands were cut from 
the filter and the amount of ‘*?-radioactivity determined. The 
specific radioactivity of ‘*‘I-labeled protein A and the exposure time 
to X-ray film varied from one experiment o another. Radioactivity 
for lanes l-4 was 252, 234, 72, and 212 cpm, respectively, for the ex- 
periment shown in the upper panel, and 498,484,604, and 1710 cpm, 
respectively, for that shown in the lower panel. Lanes 5 and 6. To 
compare the tyrosine phosphate content of cytosolic and membrane 
PLC-7 from the growth factor-treated cells, we prepared im- 
munoprecipitates from the cytosolic and membrane fractions and ad- 
justed the volumes of the dissolved immunoprecipitates loaded onto 
the gel on the basis of the amount of ‘*‘I-radioactivity present in the 
samples loaded in lanes 2 and 4, such that the lanes for cytosol (lane 
5) and membrane (lane 6) received the same amount of PLC-7. After 
separation by SDS-PAGE, proteins were transferred to nitrocellulose 
and the filter was probed with antibodies to phosphotyrosine (anti-p- 
tyr). Again the antibody-PLC-y complex was visualized by using ‘*I- 
protein A. The positions of the PLC-7 bands are indicated. PLC-7 
phosphorylated at multiple serine and tyrosine residues hows retard- 
ed mobility. 
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Fig. 2. Phosphoamino acid analysis of PLC-7 from cytosol and mem- 
brane of HER 14 cells. HER 14 cells were metabolically labeled with 
[‘*P]orthophosphate and treated with or without (control) EGF (100 
ng/ml). PLC-r was immunoprecipitated from the cytosol (A) and 
membrane (B), separated by SDS-PAGE, and visualized by 
autoradiography. Protein was extracted from the PLC-y bands and 
subjected to acid hydrolysis. Phosphoamino acids were separated on 
thin-layer chromatography plates as described (61 and the plates were 
exposed to Kodak XAR film for 12 days. The positions of spots 
associated with serine (S), threonine (T), and tyrosine (Y) are shown. 
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Fig. 3. Effect of in vitro tyrosine phosphorylation on the association 
of PLC-y with membrane. The membrane in the 100 000 x g pellet (see 
Materials and Methods) prepared from HER 14 cells that had been 
treated with 100 ng/ml EGF for 10 min at 4°C were suspended in 100 
~1 of 20 mM Hepes, pH 7.4,5 mM MnClr, and 0.1 mM NasV04, and 
divided into two equal portions. To one portion we added [y-‘*P]ATP 
(30 pM, 10 ,&i/nmol) and to the other (control) we added water. 
After 5 min, membranes were precipitated by centrifugation and 
membrane proteins were solubilized by adding 100 ~1 of extraction 
buffer. PLC-7 was immunoprecipitated with antibodies to PLC-7, 
separated on 7.5% SDS-PAGE, transferred to nitrocellulose, and 
visualized first by autoradiography (A) and then by immunoblotting 
with antibodies to PLC-7 (B). 
bands cut from the gel. As shown in Fig. 2, EGF treat- 
ment enhanced the extent of serine phosphorylation of 
PLC-7 in both cytosol and membrane fractions, where- 
as the extent of threonine phosphoryation remained vir- 
tually unchanged. Phosphotyrosine was detected only 
in PLC-7 from cytosolic fractions of EGF-treated cells. 
Thus, the extent of tyrosine phosphorylation of cyto- 
solic PLC-7 appears to be greater than that of mem- 
brane PLC-y. 
We then prepared membrane fractions from EGF- 
treated cells and incubated the fractions under a condi- 
tion where PLC-y becomes phosphorylated by the 
EGF-receptor tyrosine kinase, and evaluated if 
phosphorylation induced the release of PLC-y from 
membrane. Fig. 3A shows that incubation of mem- 
brane fractions with Mn2+ and [y-32P]ATP resulted in 
the phosphorylation of PLC-7. After SDS-PAGE, 
subsequent phosphoamino acid analysis of the PLC-y 
band cut out from the gel indicated that phosphoryla- 
tion occurred mainly at tyrosine residues (data not 
shown). Nevertheless, as shown in Fig. 3B, the content 
of PLC-7 in membrane was not altered as a result of the 
phosphorylation. Thus, tyrosine phosphorylation alone 
may not be the signal for the release of PLC-7 from 
membrane. 
4. DISCUSSION 
To avoid the complexity arising from the internaliza- 
tion of growth factor receptors at 37”C, PLC-y distri- 
bution was measured in cells equilibrated at 4°C. At 
this temperature, endocytosis ceases, and PLC-y re- 
mains associated with the receptors and is phosphory- 
lated by the receptor kinases [5,11]. In the absence of 
EGF, PLC-y was distributed in a ratio of 95 : 5 between 
cytosol and membrane, respectively. After treatment 
with EGF for 5 min at 4°C the distribution ratio was 
84 : 16. PDGF treatment also caused a similar transloca- 
tion of PLC-y. 
Translocation of PLC-y has been evaluated in A431 
cells, which express abnormally high concentrations of 
EGF receptors [17]. The amount of membrane-asso- 
ciated PLC-7 increased from 12% to 68% of total PLC- 
y after treatment with EGF at 4°C. This is a more ex- 
tensive translocation than we observed with HER 14 
cells. Although the concentration of PLC-7 is nearly 
equal in the two cell types (T. Kim and S.G. Rhee, un- 
published results), the number of EGF receptors is 
much larger in A43 1 cells (2 x 1 O6 receptors/cell) than in 
HER 14 cells (3 x 10’ receptors/cell) [13,18]. Because 
the receptors for EGF and PDGF are the enzymes 
which phosphorylate PLC-7 at multiple tyrosine 
residues [9,10], we considered the possibility that the 
transient enzyme-substrate interaction might be respon- 
sible for the growth factor-induced change in the 
subcellular distribution of PLC-7. This possibility is 
consistent with the observations that in EGF-treated 
cells cytosolic PLC-y contained more phosphorylated 
tyrosine residues that membrane-associated PLC-y, 
and that the extent of translocation appears to be 
dependent on the number of receptors. We in- 
vestigated, therefore, whether PLC-y becomes 
dissociated from membrane after it becomes 
phosphorylated by the EGF receptor. Membrane frac- 
tions containing EGF receptors and PLC-7 were in- 
cubated in the presence of [T-~~P]ATP and Mn’+. Dur- 
ing this incubation, PLC-7 became phosphorylated at 
tyrosine residue(s), but the phosphorylation did not 
reduce the concentration of PLC-y associated with 
membrane. This result suggests that PLC-y transloca- 
tion is not solely due to the formation of transient EGF 
receptor-PLC-y complexes. 
Possible modulators of PLC-y translocation are the 
proteins with which it has been shown to be associated. 
Immunoprecipitation of PLC-y with antibodies to 
PLC-y coprecipitates three proteins with molecular 
masses of 100 000,84 000, and 47 000 Da in addition to 
the EGF or PDGF receptor [5,6]. These proteins are 
also phosphoproteins and their state of phosphoryla- 
tion varies when cells are treated with EGF and PDGF 
and activators of protein kinase C and CAMP-depen- 
dent protein kinase [6,15]. It is possible that one of 
these proteins associated with PLC-y modulates the 
translocation of PLC-7, and its capacity to modulate 
the translocation may vary depending on its state of 
phosphorylation. 
REFERENCES 
[l] Berridge, M.J. (1987) Annu. Rev. Biochem. 56, 159-193. 
[2] Escobedo, J.A., Barr, P.J. and Williams, L.T. (1988) Mol. Cell. 
Biol. 8, 5126-5131. 
[3] Moolenaar, W.H., Bierman, A.J., Tilly, B.C., Verlaan, I., 
Defize, L.H.K., Honegger, A.M., Ullrich, A. and Schlessinger, 
J. (1988) EMBO J. 7, 707-710. 
35 
Volume 270, number 1,2 FEBS LETTERS September 1990 
[4] Rhee, S.G., Sub, P.-G., Ryu, S.-H. and Lee, S.Y. (1989) Science 
244, 546-550. 
[5] Wahl, M.I., Nishibe, S., Suh, P.-G., Rhee, S.G. and Carpenter, 
G. (1989) Proc. Natl. Acad. Sci. USA 86, 1568-1572. 
[6] Meisenhelder, J., Suh, P.-G., Rhee, S.G. and Hunter, T. (1989) 
Cell 57, 1108-1122. 
[7] Margolis, B., Rhee, S.G., Felder, S., Mervic, M., Lyall, R., 
Levitzki, A. Ullrich, A., Zilberstein, A. and Schlessinger, J. 
(1989) Cell 57, 1101-1107. 
[ll] Kumjian, D.A., Wahl, M.I., Rhee, S.G. and Daniel, T.O. 
(1989) Proc. Natl. Acad. Sci. USA 86, 8232-8326. 
[12] Morrison, D.K., Kaplan, D.R., Rhee, S.G. and Williams, L.T. 
(1990) Mol. Cell. Biol. 10, 2359-2366. 
[13] Honegger, A., Dull, T.J., Bellot, F., Van Obberghen, E., 
Szapary, D., Schmidt, A., Ullrich, A. and Schlessinger, J. (1988) 
EMBO J. 7, 3045-3052. 
[S] Wahl, MI., Olashaw, N.E., Nishibe, S., Rhee, S.G., Pledger, 
W.J. and Carpenter, G. (1989) Mol. Cell. Biol. 9, 2935-2943. 
[9] Kim, J.W., Sim, S.S., Kim, U.-H., Nishibe, S., Wahl, M.I., 
Carpenter, G. and Rhee, S.G. (1990) J. Biol. Chem. 265, 
3940-3943. 
[14] Suh, P.-G., Ryu, S.H., Choi, WC., Lee, K.Y. and Rhee, S.G. 
(1988) J. Biol. Chem. 263, 14497-14504. 
[15] Kim, U.-H., Kim, J.W. and Rhee, S.G. (1989) J. Biol. Chem. 
264, 20167-20170. 
[16] Laemmli, U.K. (1970) Nature 227, 680-685. 
1171 Todderud, G., Wahl, MI., Rhee, S.G. and Carpenter, G. (1990) 
Science, in press. 
[lo] Nishibe, S., Wahl, MI., Rhee, S.G. and Carpenter, G. (1990) J. [18] Wahl, M.I., Sweatt, J.D. and Carpenter, G. (1987) Biochem. 
Biol. Chem. 265, 3944-3948. Biophys. Res. Commun. 142, 688-695. 
36 
